45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
20,728
Insurances with rates
34
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
3917846
$58,450
ocrelizumab hyaluronidase 920 mg 23 000 units 23
Gross
$162,362
3917846
$58,450
ocrelizumab hyaluronidase 920 mg 23 000 units 23
Gross
$162,362
3917846
$58,450
ocrelizumab hyaluronidase 920 mg 23 000 units 23
Gross
$162,362
8215713
$51,141
INSERT/REPOS ICD GEN&LEAD SC
Gross
$142,058
8215713
$51,141
INSERT/REPOS ICD GEN&LEAD SC
Gross
$142,058
8215714
$51,141
INSERT/REPOS ICD GEN&LEAD DC
Gross
$142,058
8215714
$51,141
INSERT/REPOS ICD GEN&LEAD DC
Gross
$142,058
8215718
$51,141
ICD GEN ONLY/OLD MULTI LEAD
Gross
$142,058
8215718
$51,141
ICD GEN ONLY/OLD MULTI LEAD
Gross
$142,058
8215721
$51,141
ICD GEN EXCHANGE, MULTI
Gross
$142,058
8215721
$51,141
ICD GEN EXCHANGE, MULTI
Gross
$142,058
8215713
$51,141
INSERT/REPOS ICD GEN&LEAD SC
Gross
$142,058
8215714
$51,141
INSERT/REPOS ICD GEN&LEAD DC
Gross
$142,058
8215718
$51,141
ICD GEN ONLY/OLD MULTI LEAD
Gross
$142,058
8215721
$51,141
ICD GEN EXCHANGE, MULTI
Gross
$142,058
8215716
$38,408
INS OR REPL S-ICD SYS
Gross
$106,690
8215716
$38,408
INS OR REPL S-ICD SYS
Gross
$106,690
8215716
$38,408
INS OR REPL S-ICD SYS
Gross
$106,690
8215719
$38,028
ICD GEN ONLY/OLD DUAL LEAD
Gross
$105,632
8215719
$38,028
ICD GEN ONLY/OLD DUAL LEAD
Gross
$105,632
8215720
$38,028
ICD GEN EXCHANGE, SINGLE
Gross
$105,632
8215720
$38,028
ICD GEN EXCHANGE, SINGLE
Gross
$105,632
8215722
$38,028
ICD GEN EXCHANGE, DUAL
Gross
$105,632
8215722
$38,028
ICD GEN EXCHANGE, DUAL
Gross
$105,632
8215719
$38,028
ICD GEN ONLY/OLD DUAL LEAD
Gross
$105,632
8215720
$38,028
ICD GEN EXCHANGE, SINGLE
Gross
$105,632
8215722
$38,028
ICD GEN EXCHANGE, DUAL
Gross
$105,632
3917895
$33,912
ravulizumab 1100 mg 11 mL Inj Soln
Gross
$94,199
3917895
$33,912
ravulizumab 1100 mg 11 mL Inj Soln
Gross
$94,199
3917895
$33,912
ravulizumab 1100 mg 11 mL Inj Soln
Gross
$94,199
3919552
$29,225
ocrelizumab 300 mg 10 mL Inj Soln
Gross
$81,181
3919552
$29,225
ocrelizumab 300 mg 10 mL Inj Soln
Gross
$81,181
3919552
$29,225
ocrelizumab 300 mg 10 mL Inj Soln
Gross
$81,181
3911104
$28,916
pegloticase 8 mg mL Sol
Gross
$80,324
3911104
$28,916
pegloticase 8 mg mL Sol
Gross
$80,324
3911104
$28,916
pegloticase 8 mg mL Sol
Gross
$80,324
8215760
$27,228
PM GEN ONLY/OLD LEADS
Gross
$75,632
8215760
$27,228
PM GEN ONLY/OLD LEADS
Gross
$75,632
8215762
$27,228
PM GEN EXCHANGE, MULTI
Gross
$75,632
8215762
$27,228
PM GEN EXCHANGE, MULTI
Gross
$75,632
8215760
$27,228
PM GEN ONLY/OLD LEADS
Gross
$75,632
8215762
$27,228
PM GEN EXCHANGE, MULTI
Gross
$75,632
8552143
$25,279
37294-TIB/PER REVASC STNT & ATHER-RT,COMPLEX
Gross
$70,221
8552143
$25,279
37294-TIB/PER REVASC STNT & ATHER-RT,COMPLEX
Gross
$70,221
8552144
$25,279
37294-TIB/PER REVASC STNT & ATHER-LT,COMPLEX
Gross
$70,221
8552144
$25,279
37294-TIB/PER REVASC STNT & ATHER-LT,COMPLEX
Gross
$70,221
8552147
$25,279
37292-TIB/PER REVASC STNT & ATHER-RT,SIMPLE
Gross
$70,221
8552147
$25,279
37292-TIB/PER REVASC STNT & ATHER-RT,SIMPLE
Gross
$70,221
8552148
$25,279
37292-TIB/PER REVASC STNT & ATHER-LT,SIMPLE
Gross
$70,221
8552148
$25,279
37292-TIB/PER REVASC STNT & ATHER-LT,SIMPLE
Gross
$70,221
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 3917846 | ocrelizumab hyaluronidase 920 mg 23 000 units 23 | $162,362 | $58,450 | — | — | 2 |
| 3917846 | ocrelizumab hyaluronidase 920 mg 23 000 units 23 | $162,362 | $58,450 | — | — | 11 |
| 3917846 | ocrelizumab hyaluronidase 920 mg 23 000 units 23 | $162,362 | $58,450 | — | — | 19 |
| 8215713 | INSERT/REPOS ICD GEN&LEAD SC | $142,058 | $51,141 | — | — | 1 |
| 8215713 | INSERT/REPOS ICD GEN&LEAD SC | $142,058 | $51,141 | — | — | 18 |
| 8215714 | INSERT/REPOS ICD GEN&LEAD DC | $142,058 | $51,141 | — | — | 1 |
| 8215714 | INSERT/REPOS ICD GEN&LEAD DC | $142,058 | $51,141 | — | — | 18 |
| 8215718 | ICD GEN ONLY/OLD MULTI LEAD | $142,058 | $51,141 | — | — | 1 |
| 8215718 | ICD GEN ONLY/OLD MULTI LEAD | $142,058 | $51,141 | — | — | 18 |
| 8215721 | ICD GEN EXCHANGE, MULTI | $142,058 | $51,141 | — | — | 1 |
| 8215721 | ICD GEN EXCHANGE, MULTI | $142,058 | $51,141 | — | — | 18 |
| 8215713 | INSERT/REPOS ICD GEN&LEAD SC | $142,058 | $51,141 | — | — | 20 |
| 8215714 | INSERT/REPOS ICD GEN&LEAD DC | $142,058 | $51,141 | — | — | 20 |
| 8215718 | ICD GEN ONLY/OLD MULTI LEAD | $142,058 | $51,141 | — | — | 20 |
| 8215721 | ICD GEN EXCHANGE, MULTI | $142,058 | $51,141 | — | — | 20 |
| 8215716 | INS OR REPL S-ICD SYS | $106,690 | $38,408 | — | — | 1 |
| 8215716 | INS OR REPL S-ICD SYS | $106,690 | $38,408 | — | — | 18 |
| 8215716 | INS OR REPL S-ICD SYS | $106,690 | $38,408 | — | — | 20 |
| 8215719 | ICD GEN ONLY/OLD DUAL LEAD | $105,632 | $38,028 | — | — | 1 |
| 8215719 | ICD GEN ONLY/OLD DUAL LEAD | $105,632 | $38,028 | — | — | 18 |
| 8215720 | ICD GEN EXCHANGE, SINGLE | $105,632 | $38,028 | — | — | 1 |
| 8215720 | ICD GEN EXCHANGE, SINGLE | $105,632 | $38,028 | — | — | 18 |
| 8215722 | ICD GEN EXCHANGE, DUAL | $105,632 | $38,028 | — | — | 1 |
| 8215722 | ICD GEN EXCHANGE, DUAL | $105,632 | $38,028 | — | — | 18 |
| 8215719 | ICD GEN ONLY/OLD DUAL LEAD | $105,632 | $38,028 | — | — | 20 |
| 8215720 | ICD GEN EXCHANGE, SINGLE | $105,632 | $38,028 | — | — | 20 |
| 8215722 | ICD GEN EXCHANGE, DUAL | $105,632 | $38,028 | — | — | 20 |
| 3917895 | ravulizumab 1100 mg 11 mL Inj Soln | $94,199 | $33,912 | — | — | 2 |
| 3917895 | ravulizumab 1100 mg 11 mL Inj Soln | $94,199 | $33,912 | — | — | 12 |
| 3917895 | ravulizumab 1100 mg 11 mL Inj Soln | $94,199 | $33,912 | — | — | 21 |
| 3919552 | ocrelizumab 300 mg 10 mL Inj Soln | $81,181 | $29,225 | — | — | 2 |
| 3919552 | ocrelizumab 300 mg 10 mL Inj Soln | $81,181 | $29,225 | — | — | 12 |
| 3919552 | ocrelizumab 300 mg 10 mL Inj Soln | $81,181 | $29,225 | — | — | 21 |
| 3911104 | pegloticase 8 mg mL Sol | $80,324 | $28,916 | — | — | 2 |
| 3911104 | pegloticase 8 mg mL Sol | $80,324 | $28,916 | — | — | 12 |
| 3911104 | pegloticase 8 mg mL Sol | $80,324 | $28,916 | — | — | 21 |
| 8215760 | PM GEN ONLY/OLD LEADS | $75,632 | $27,228 | — | — | 1 |
| 8215760 | PM GEN ONLY/OLD LEADS | $75,632 | $27,228 | — | — | 18 |
| 8215762 | PM GEN EXCHANGE, MULTI | $75,632 | $27,228 | — | — | 1 |
| 8215762 | PM GEN EXCHANGE, MULTI | $75,632 | $27,228 | — | — | 18 |
| 8215760 | PM GEN ONLY/OLD LEADS | $75,632 | $27,228 | — | — | 20 |
| 8215762 | PM GEN EXCHANGE, MULTI | $75,632 | $27,228 | — | — | 20 |
| 8552143 | 37294-TIB/PER REVASC STNT & ATHER-RT,COMPLEX | $70,221 | $25,279 | — | — | 1 |
| 8552143 | 37294-TIB/PER REVASC STNT & ATHER-RT,COMPLEX | $70,221 | $25,279 | — | — | 18 |
| 8552144 | 37294-TIB/PER REVASC STNT & ATHER-LT,COMPLEX | $70,221 | $25,279 | — | — | 1 |
| 8552144 | 37294-TIB/PER REVASC STNT & ATHER-LT,COMPLEX | $70,221 | $25,279 | — | — | 18 |
| 8552147 | 37292-TIB/PER REVASC STNT & ATHER-RT,SIMPLE | $70,221 | $25,279 | — | — | 1 |
| 8552147 | 37292-TIB/PER REVASC STNT & ATHER-RT,SIMPLE | $70,221 | $25,279 | — | — | 18 |
| 8552148 | 37292-TIB/PER REVASC STNT & ATHER-LT,SIMPLE | $70,221 | $25,279 | — | — | 1 |
| 8552148 | 37292-TIB/PER REVASC STNT & ATHER-LT,SIMPLE | $70,221 | $25,279 | — | — | 18 |
Showing top 50 of 20,728 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.